Additional Information

Description

Cathflo Activase 2 mg Vial is a recombinant tissue plasminogen activator (rtPA) used primarily for the management of occluded central venous access devices, such as catheters or ports. It works by breaking down blood clots that may obstruct the catheter, restoring its functionality. This action is facilitated through the conversion of plasminogen to plasmin, which subsequently dissolves fibrin clots.

The medication is presented in a 2 mg vial, which is reconstituted with sterile water for injection to create a solution suitable for direct catheter administration. The drug is typically administered through the occluded catheter and allowed to dwell for a specified period, depending on the severity of the clot. The dosage and duration of treatment are determined by the healthcare provider.

Common side effects of Cathflo Activase include bleeding at the catheter insertion site, bruising, and allergic reactions. Serious adverse effects, though rare, can involve systemic bleeding complications, which necessitate careful patient monitoring during administration.